Search results
3. Ota T, Suzuki Y et al. (2004) Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. 4. Suzuki Y, Sugano S. (2003) Construction of a full-length enriched and a 5'-end enriched cDNA library using the oligo-capping method. Methods Mol Biol. 2003; 221:73-91. Future Plan
Apr 9, 2019 · Single Molecule and Single Cell Sequencing. This book presents an overview of the recent technologies in single molecule and single cell sequencing. These sequencing technologies are revolutionizing the way of the genomic studies and the understanding of complex biological systems. The PacBio sequencer has enabled extremely long-read sequencing ...
Yutaka Suzuki 1 , Ayako Suzuki 1 Yasuhiko Haga 1 , Yoshitaka Sakamoto 1 , Miyuki Arai 1 , Yutaka Suzuki 1 ... PDF Full Text Related articles.
Dr. Yutaka Suzuki is a professor at the Department of Computational Biology and Medical Sciences, University of Tokyo (UTokyo), Japan. After he graduated from UTokyo in 1999, he spent one year at the Genome Science Center, RIKEN and then moved back to UTokyo where he researched full-length cDNA sequencing analysis.
Dec 20, 2021 · 20 December 2021, 2:05 PM. Yutaka Suzuki, the general manager, Super GT team director, and chief engineer of GT500 vehicle development for NISMO (Nissan Motorsports International), died Sunday at the age of 56 after battling an undisclosed illness throughout this year. Suzuki had been an integral member of NISMO as both an engineer and ...
Apr 1, 2004 · Yutaka Suzuki Y. Atomi. +10 authors. K. Suda. Medicine. Pancreas. 1 April 2004. TLDR. A multiinstitutional, retrospective study of 1379 cases of intraductal papillary mucinous tumor (IPMT) and 179 cases of mucinous cystic tumor (MCT) of the pancreas found IPMT and MCT show distinct clinicopathologic and prognostic differences. Expand.
Sep 26, 2019 · Professor Yutaka Suzuki shared his experience using nanopore sequencing for whole-genome sequencing of clinical cancer samples. Beginning with lung cancer, Yutaka's team performed targeted amplicon sequencing on PromethION to accurately identify single-base mutations and alleles of cancer-associated genes (such as EGFR , KRAS , NRAS, and NF1 genes).
